Aguirre Jarrad Mattieuinsider trades

In SEC Form 4 filings, Aguirre Jarrad Mattieu is listed as Chief Medical Officer of Lyell Immunopharma, Inc. (LYEL). In the last 90 days, Aguirre Jarrad Mattieu sold $3.6K of Lyell Immunopharma, Inc. (LYEL) on the open market and bought none.

Companies and roles

Company	Role	Transactions	Last filed
LYELLyell Immunopharma, Inc.	Chief Medical Officer	2	Oct 13

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-10

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
LYELLyell Immunopharma, Inc.	Oct 12	Oct 13	S	422	$8.63	Sale −$3,642	19,857	No	Form 4
LYELLyell Immunopharma, Inc.	Sep 10	Sep 10	A · derivative	47,500	$12.20	$579,500	47,500	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.